Cargando…
Susceptibility Factors of Stomach for SARS-CoV-2 and Treatment Implication of Mucosal Protective Agent in COVID-19
Objectives: This work aims to study the gastrointestinal (GI) symptoms in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients and the susceptibility factors of the stomach for SARS-CoV-2. Materials and Methods: We investigated the SARS-CoV-2 susceptibility by analyzing the...
Autores principales: | Zhang, Min, Feng, Chao, Zhang, Xingchen, Hu, Shuofeng, Zhang, Yuan, Min, Min, Liu, Bing, Ying, Xiaomin, Liu, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840564/ https://www.ncbi.nlm.nih.gov/pubmed/33521016 http://dx.doi.org/10.3389/fmed.2020.597967 |
Ejemplares similares
-
Uncommon mucosal metastases to the stomach
por: Kanthan, R, et al.
Publicado: (2009) -
Primary Mucosal Melanoma of the Stomach
por: Phillips, O., et al.
Publicado: (2018) -
Dolichos lablab L. extracts as pharmanutrient for stress-related mucosal disease in rat stomach
por: An, Jeong Min, et al.
Publicado: (2020) -
Development and Validation of a Novel Prognosis Prediction Model for Patients With Stomach Adenocarcinoma
por: Wang, Tong, et al.
Publicado: (2021) -
Colonic mucosal biopsy location can not affect the results of mucosal metabolomics and mucosal microbiota analysis in IBS
por: Zhu, Huiting, et al.
Publicado: (2023)